筛选条件 共查询到160条结果
排序方式
Hyperhidrosis in Parkinson's disease: a 3-year prospective cohort study

期刊: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022; 36 (7)

Background Although hyperhidrosis is a common symptom in patients with Parkinson's disease (PD), no study has yet examined it longitudinally. Objectiv......

JIF:2.575

A topical emollient mitigates the progression of cognitive impairment in the elderly: a randomized, open-label pilot trial

期刊: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022; 36 (8)

Background Cognitive impairment is common in the elderly. Prior studies suggest a link between chronic inflammation and cognitive dysfunction, while a......

JIF:2.575

Incidence and familial clustering of infantile haemangiomas: a multicentre study

期刊: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022; 36 (9)

Background The exact incidence of infantile haemangiomas (IH) in the Chinese population is still unknown. A positive family history of IH was consider......

JIF:2.575

iTRAQ-based quantitative proteomics reveals biomarkers/pathways in psoriasis that can predict the efficacy of methotrexate

期刊: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022; 36 (10)

Background Methotrexate (MTX) is the first-line medicine to treat psoriasis. So far, there has been less research on protein biomarkers to predict its......

JIF:2.575

Unique motif shared by HLA-B59:01 and HLA-B55:02 is associated with methazolamide-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese

期刊: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022; 36 (6)

Background Methazolamide (MTZ) has been occasionally linked to the lethal Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), which a......

JIF:2.575

Novel MSH6 mutation predicted metastasis in eyelid and periocular squamous cell carcinoma

期刊: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022; 36 (12)

Background Our previous research revealed the relative local aggressiveness of eyelid and periocular squamous cell carcinoma (EPSCC), but its distinct......

JIF:2.575

The efficacy and safety of tofacitinib, peficitinib, solcitinib, baricitinib, abrocitinib and deucravacitinib in plaque psoriasis - A network meta-analysis

期刊: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022; 36 (11)

Janus kinase (JAK) inhibitors are novel treatment approaches for psoriasis. However, there is no direct comparison of JAK inhibitors in plaque psorias......

JIF:2.575

共160条页码: 1/11页15条/页